Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO1997017075) TOPICAL FOAMABLE PHARMACEUTICAL COMPOSITION FOR TREATING SKIN DISEASES INDUCED BY OVAL PITYROSPORUM
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/1997/017075 International Application No.: PCT/FR1996/001753
Publication Date: 15.05.1997 International Filing Date: 07.11.1996
Chapter 2 Demand Filed: 02.06.1997
IPC:
A61K 9/12 (2006.01) ,A61K 31/4418 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
10
Dispersions; Emulsions
12
Aerosols; Foams
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
435
having six-membered rings with one nitrogen as the only ring hetero atom
44
Non-condensed pyridines; Hydrogenated derivatives thereof
4418
having a carbocyclic ring directly attached to the heterocyclic ring, e.g. cyproheptadine
Applicants:
PIERRE FABRE MEDICAMENT [FR/FR]; 45, place Abel-Gance F-92100 Boulogne-Billancourt, FR
Inventors:
LEVERD, Elie; FR
LACROUX, Martine; FR
MROZ-COMBESSIS, Danielle; FR
BOUGARET, Joël; FR
MROZ, Christian; FR
Agent:
MARTIN, Jean-Jacques ; Cabinet Regimbeau 26, avenue Kléber F-75116 Paris, FR
Priority Data:
95/1320208.11.1995FR
Title (EN) TOPICAL FOAMABLE PHARMACEUTICAL COMPOSITION FOR TREATING SKIN DISEASES INDUCED BY OVAL PITYROSPORUM
(FR) COMPOSITION PHARMACEUTIQUE TOPIQUE MOUSSANTE POUR LE TRAITEMENT DES DERMATOSES, INDUITES PAR PITYROSPORUM OVALE
Abstract:
(EN) A topical foamable pharmaceutical composition for treating skin diseases induced by oval Pityrosporum, containing (i) 0.1-10.0 wt %, preferably 2.1-6.0 wt % of ciclopirox or ciclopiroxolamine as the antifungal active principle, and (ii) 0.5-35.0 wt %, preferably 3-20 wt % and especially 5-15 wt % of a surfactant selected from alkylbetaines, alkylamidobetaines, cocamidoalkylamines and derivatives thereof, as well as mixtures thereof.
(FR) Composition pharmaceutique moussante à usage topique destinée au traitement des dermatoses induites par Pityrosporum ovale, caractérisée en ce qu'elle contient: (i) de 0,1 à 10,0 % en poids, de préférence 2,1 à 6,0 %, de ciclopirox ou de ciclopiroxolamine, et à titre de principe actif anti-fongique, (ii) 0,5 % à 35,0 % en poids, de préférence de 3 à 20 %, et plus particulièrement de 5 à 15 %, d'un tensio-actif choisi parmi les alkyl-bétaïnes, des alkyl-amidobétaïnes, les cocamidoalkylamines et leurs dérivés, ainsi que leurs mélanges.
Designated States: European Patent Office (AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
Publication Language: French (FR)
Filing Language: French (FR)
Also published as:
EP0862433DE000069623641PT862433FR2740685